glp1 and glp2 tirzepatide Pharmacogenomics of Tirzepatide: Genomic Insights into Dual GIP/GLP-1 Agonist Response in Type 2 Diabetes Atherosclerosis Semaglutide & Tirzepatide Weight Loss

Last year, Washingtons Pharmacy Quality Assurance Commission, stopped production at Aequita Pharmacy, the compounder that also owns Mochi Health and was used to produce its tirzepatide drugs, because it allowed untrained and unqualified staff to perform sterile compounding and didnt properly supervise staff

As a prior authorization requirement, patients must have pre-existing atherosclerotic cardiovascular disease and/or chronic kidney disease, and a medical determination that theyre not a good candidate for empagliflozin (brand name: Jardiance)

This could be beneficial, representing additive metabolic improvement, or it could create situations where blood glucose drops further than intended, which circles back to the hypoglycemia risk that gets its own section below

For most patients, the benefits of improved blood sugar control and weight loss likely outweigh the inconvenience of feeling cold